Riverside-backed BioDue Acquires Biokosmes and Rolf Kullgren from Venture Life

The Riverside Company Acquires Controlling Stake in BioDue S.p.A

November 16, 2022

Pharmaceuticals

The Riverside Company has signed a definitive agreement to acquire a controlling stake in BioDue S.p.A, an Italian developer and manufacturer of dietary supplements, medical devices and cosmetics. Riverside plans to pursue a pan‑European buy‑and‑build strategy to expand BioDue's product range and commercial reach, while supporting operational improvements across its production sites.

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

September 18, 2024

Healthcare Services

Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

Syner-G BioPharma Group (Riverside Partners) Acquires RMC Pharmaceutical Solutions

January 24, 2023

Healthcare Services

Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired RMC Pharmaceutical Solutions, an outsourced CMC and quality management services provider based in Colorado. The add-on strengthens Syner-G's pharmaceutical science capabilities—particularly biologics and cell & gene therapy development—by integrating RMC's process and analytical development, regulatory strategy, and quality management expertise.

The Riverside Company Invests in Western Botanicals

February 12, 2026

Food & Beverage

The Riverside Company has made a growth investment in Western Botanicals, a Spanish Fork, Utah-based contract development and manufacturing organization (CDMO) of vitamins, minerals and supplements. Riverside will partner with management — which retains a meaningful ownership stake — to support organic growth, expand product and format capabilities, and pursue an M&A strategy to broaden Western Botanicals' capabilities.

BioSelective Capital Investments Acquires BioDuro's Irvine Drug Product Operations to Form Forma Life Sciences

February 4, 2026

Pharmaceuticals

BioSelective Capital Investments, together with Shayan Enterprises, LLC, acquired BioDuro’s drug product development and manufacturing operations in Irvine, California and formed Forma Life Sciences, Inc. The transaction transfers two U.S.-based oral solid dosage development and manufacturing facilities (≈65,000 sq ft and ≈40,000 sq ft) to the new Delaware-held company; BioDuro (an Advent portfolio company) sold the assets.